|
CDC27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.374800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.031440E-01 |
| Normal-vs-Stage2 |
7.413200E-01 |
| Normal-vs-Stage3 |
9.402000E-01 |
| Normal-vs-Stage4 |
6.220600E-01 |
| Stage1-vs-Stage2 |
4.738400E-01 |
| Stage1-vs-Stage3 |
7.241900E-02 |
| Stage1-vs-Stage4 |
1.961820E-02 |
| Stage2-vs-Stage3 |
7.771400E-01 |
| Stage2-vs-Stage4 |
4.949000E-01 |
| Stage3-vs-Stage4 |
5.589800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.296000E-01 |
| Normal-vs-AfricanAmerican |
2.172800E-01 |
| Normal-vs-Asian |
1.261240E-01 |
| Caucasian-vs-AfricanAmerican |
2.615700E-02 |
| Caucasian-vs-Asian |
3.042200E-01 |
| AfricanAmerican-vs-Asian |
3.777800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.737400E-01 |
| Normal-vs-Female |
1.797360E-01 |
| Male-vs-Female |
1.923770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.636400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.993950E-01 |
| Normal-vs-Age(61-80Yrs) |
5.536800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.298600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.832600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.710800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.034000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.334000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.715030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.350800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.451800E-02 |
| Normal-vs-Grade 2 |
2.820300E-02 |
| Normal-vs-Grade 3 |
6.672200E-01 |
| Normal-vs-Grade 4 |
4.319400E-01 |
| Grade 1-vs-Grade 2 |
5.343400E-01 |
| Grade 1-vs-Grade 3 |
2.534100E-02 |
| Grade 1-vs-Grade 4 |
2.041800E-02 |
| Grade 2-vs-Grade 3 |
5.394000E-04 |
| Grade 2-vs-Grade 4 |
1.660120E-03 |
| Grade 3-vs-Grade 4 |
5.883800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.823800E-02 |
| Normal-vs-ccB subtype |
4.400600E-01 |
| ccA subtype-vs-ccB subtype |
7.912000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.875220E-01 |
| Normal-vs-N1 |
7.219400E-01 |
| N0-vs-N1 |
7.942000E-01 |
|
|
